Improving Cognition With Neurodegradation Countermeasure
Conditions: Hemodynamics; Caffeine; TeaCrine; Cognitive Change Interventions: Dietary Supplement: TeaCrine and Caffeine; Dietary Supplement: Caffeine; Other: Placebo Sponsor: University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
Conditions: Metabolic Syndrome; Obesity Interventions: Drug: coated beads glucose (8 g) and caffeine anhydrous; Drug: coated beads glucose (8 g); Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors: Aphaia Pharma US LLC; ACC GmbH Analytical Clinical Concepts, Germany; Nova-Clin Medical Research Center S.R.L., Romania; BioClinica, Inc.; Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Improving Cognition With Neurodegradation Countermeasure
Conditions: Hemodynamics; Caffeine; TeaCrine; Cognitive Change Interventions: Dietary Supplement: TeaCrine and Caffeine; Dietary Supplement: Caffeine; Other: Placebo Sponsor: University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
Conditions: Metabolic Syndrome; Obesity Interventions: Drug: coated beads glucose (8 g) and caffeine anhydrous; Drug: coated beads glucose (8 g); Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors: Aphaia Pharma US LLC; ACC GmbH Analytical Clinical Concepts, Germany; Nova-Clin Medical Research Center S.R.L., Romania; BioClinica, Inc.; Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Improving Cognition With Neurodegradation Countermeasure
Conditions: Hemodynamics; Caffeine; TeaCrine; Cognitive Change Interventions: Dietary Supplement: TeaCrine and Caffeine; Dietary Supplement: Caffeine; Other: Placebo Sponsor: University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
Conditions: Metabolic Syndrome; Obesity Interventions: Drug: coated beads glucose (8 g) and caffeine anhydrous; Drug: coated beads glucose (8 g); Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors: Aphaia Pharma US LLC; ACC GmbH Analytical Clinical Concepts, Germany; Nova-Clin Medical Research Center S.R.L., Romania; BioClinica, Inc.; Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Improving Cognition With Neurodegradation Countermeasure
Conditions: Hemodynamics; Caffeine; TeaCrine; Cognitive Change Interventions: Dietary Supplement: TeaCrine and Caffeine; Dietary Supplement: Caffeine; Other: Placebo Sponsor: University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
Conditions: Metabolic Syndrome; Obesity Interventions: Drug: coated beads glucose (8 g) and caffeine anhydrous; Drug: coated beads glucose (8 g); Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors: Aphaia Pharma US LLC; ACC GmbH Analytical Clinical Concepts, Germany; Nova-Clin Medical Research Center S.R.L., Romania; BioClinica, Inc.; Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Improving Cognition With Neurodegradation Countermeasure
Conditions: Hemodynamics; Caffeine; TeaCrine; Cognitive Change Interventions: Dietary Supplement: TeaCrine and Caffeine; Dietary Supplement: Caffeine; Other: Placebo Sponsor: University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
Conditions: Metabolic Syndrome; Obesity Interventions: Drug: coated beads glucose (8 g) and caffeine anhydrous; Drug: coated beads glucose (8 g); Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors: Aphaia Pharma US LLC; ACC GmbH Analytical Clinical Concepts, Germany; Nova-Clin Medical Research Center S.R.L., Romania; BioClinica, Inc.; Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Improving Cognition With Neurodegradation Countermeasure
Conditions: Hemodynamics; Caffeine; TeaCrine; Cognitive Change Interventions: Dietary Supplement: TeaCrine and Caffeine; Dietary Supplement: Caffeine; Other: Placebo Sponsor: University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
Conditions: Metabolic Syndrome; Obesity Interventions: Drug: coated beads glucose (8 g) and caffeine anhydrous; Drug: coated beads glucose (8 g); Drug: uncoated beads glucose (8 g) and caffeine anhydrous Sponsors: Aphaia Pharma US LLC; ACC GmbH Analytical Clinical Concepts, Germany; Nova-Clin Medical Research Center S.R.L., Romania; BioClinica, Inc.; Galephar Pharmaceutical Research (PR), Inc, Puerto Rico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Improving Cognition With Neurodegradation Countermeasure
Conditions: Hemodynamics; Caffeine; TeaCrine; Cognitive Change Interventions: Dietary Supplement: TeaCrine and Caffeine; Dietary Supplement: Caffeine; Other: Placebo Sponsor: University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials
Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women
Condition: Female Sexual Arousal Disorder Intervention: Drug: Caffeine Sponsor: University of Texas at Austin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2023 Category: Research Source Type: clinical trials
